3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
19
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Sleep Wake Disorders
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Anxiety Disorders
1
Interventions
Specimen Handling
47
Magnetic Resonance Spectroscopy
38
Cyclophosphamide
28
Vincristine
22
Radiation
19
Dexamethasone
19
Etoposide
18
Cisplatin
18
Carboplatin
17
Biopsy
17
Radiotherapy
16
Doxorubicin
13
Cytarabine
13
daratumumab
12
Leucovorin
12
Methotrexate
11
Gemcitabine
11
X-Rays
10
Standard of Care
10
Platinum
10
Docetaxel
10
durvalumab
9
Rituximab
9
Radiotherapy, Intensity-Modulated
9
Prednisone
9
Practice Guidelines as Topic
9
Calcium Dobesilate
9
1,2-diaminocyclohexaneplatinum II citrate
9
merphos
8
dexamethasone acetate
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Counseling
×
90 days
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts